Articles > Devices & Technology

Executives of the Big Three pharma companies involved in diabetes research, development, and manufacturing — Eli Lilly and Co., Novo Nordisk, and Sanofi — spoke publicly this week at JPMorgan’s 2020 Healthcare conference on issues related to insulin pricing and supply.

Tandem t:slim X 2 pump with control IQ technology

Last month, the FDA approved the Tandem Diabetes Care update to its t:slim X2 insulin pump Control-IQ technology, clearing the way for the first automated and interoperable insulin dosing system on the U.S. market.

logo for French pharma manufacturer Sanofi

Sanofi, the French pharmaceutical giant which manufactures the long-acting insulin Lantus, announced Monday that it would no longer be investing in research for new drugs to treat diabetes. The manufacturer also told investors it would no longer be investigating new treatments for cardiovascular health. “To be out of cardiovascular and diabetes is not easy for …

Two airline pilots monitoring instruments

The FAA is moving to allow pilots with type 1 diabetes to take command of U.S.-based commercial flights, reports CNN.

Tandem Insulin pump

A new study published in the New England Journal of Medicine (NEJM) showed promising results for closed-loop insulin delivery systems, the journal and participating manufacturers reported last week.

One Drop Meters Now Being Sold at Walmart

Walmart becomes the second major retail outlet to sell the One Drop product line.

Dexcom Receives FDA Approval For G6 Pro CGM

The device, similar to the G6 on the market, is intended for use by clinicians that want their patients to test out the device.

Freestyle Libre CGM Aided Blood Sugar Management of Homebound Patients with Diabetes

Two U.K. case-based studies found evidence that use of the devices helped uncover bouts of low blood sugar among frail, elderly patients.

Omnipod with app.

Insulet will now be able to market their continuous insulin delivery system as an integrated insulin pump.

Why CGM May Be the Most Important Technology for People with Type 1 Diabetes

New research affirms the importance of CGM use in blood sugar management. We discuss the value of CGMs with Dr. Tomas Walker, the Senior Medical Director for Dexcom.